Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Amortizatization of Intangibles (2021 - 2025)

Historic Amortizatization of Intangibles for Haemonetics (HAE) over the last 7 years, with Q4 2025 value amounting to $1.3 million.

  • Haemonetics' Amortizatization of Intangibles fell 6040.11% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.5 million, marking a year-over-year decrease of 4605.52%. This contributed to the annual value of $15.0 million for FY2025, which is 34684.79% up from last year.
  • Latest data reveals that Haemonetics reported Amortizatization of Intangibles of $1.3 million as of Q4 2025, which was down 6040.11% from $2.1 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Amortizatization of Intangibles ranged from a high of $5.3 million in Q3 2021 and a low of -$5.3 million during Q2 2022
  • In the last 4 years, Haemonetics' Amortizatization of Intangibles had a median value of $3.0 million in 2024 and averaged $2.4 million.
  • Data for Haemonetics' Amortizatization of Intangibles shows a peak YoY increase of 2121.3% (in 2025) and a maximum YoY decrease of 6040.11% (in 2025) over the last 5 years.
  • Haemonetics' Amortizatization of Intangibles (Quarter) stood at $5.3 million in 2021, then tumbled by 200.0% to -$5.3 million in 2022, then soared by 163.1% to $3.3 million in 2024, then crashed by 60.4% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q4 2025, $2.1 million for Q3 2025, and $2.4 million during Q2 2025.